High-Precision Prediction of Breast Cancer Recurrence via Blood Test: Visualizing Signs of Treatment Resistance through cfDNA Nucleosome Analysis
NQ Score
55/100
N1 Content Completeness
10
AI Summary (NQ-processed)
A research group at Kumamoto University has developed a new method to predict breast cancer recurrence with high precision by analyzing the nucleosome structure and fragmentation patterns of cell-free DNA (cfDNA) in blood. By combining analysis of the RERE and SYNPO2 gene regions with machine learning, the team visualized signs of treatment resistance that were difficult to detect with conventional mutation-focused tests, paving the way for next-generation, low-cost, minimally invasive liquid biopsies.
AI Analysis
Frequently Asked Questions
- Q: Is this technology immediately available for clinical use in Taiwan?
- A: This research is in the clinical validation stage. It will require large-scale cohort studies before being considered for integration into clinical guidelines in Taiwan and other regions.